Pharma News

Pharma Courses 
PAGE Admission

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Dr. Reddy’s today announced the launch of HAiROOTZ™, the first hair growth supplement to be marketed in India as over-the-counter (OTC) by the company. HAiROOTZ™ comes from the same branch of business that markets MINTOPTM, the No. 1 dermatologist recommended brand in the country.

  • Researchers have successfully engineered E coli bacteria to produce new forms of antibiotics — including three that show promise in fighting drug-resistant bacteria. Blaine A Pfeifer, an associate professor of chemical and biological engineering in the University at Buffalo School of Engineering and Applied Sciences, has been studying how to engineer Escherichia coli (E coli) to generate new varieties of erythromycin, a popular antibiotic.

  • The US Food and Drug Administration (FDA) has accepted for review Teva Pharmaceutical's Biologics License Application (BLA) for reslizumab for the treatment of inadequately controlled asthma in adult and adolescent patients with elevated blood eosinophils, despite an inhaled corticosteroid (ICS)-based regimen.

  • Everybody loves  chocolate.  A new research found tentative evidence that eating chocolate in modest quantities may be good for the heart. Heart researchers at the University of Aberdeen found that eating up to 100g of chocolate a day lowered the risk of and reduced the risk of suffering a stroke by 23 per cent. The study is published in the Heart.

  • Memories that are 'lost' as a result of traumatic injury, stress or diseases such as Alzheimer's can be recalled by activating brain cells with light, MIT scientists, including one of Indian-origin, have found. Researchers were able to reactivate memories that could not otherwise be retrieved, using a technology known as optogenetics.

  • 22 June 2015
    Novel drug 'ixekizumab' miracle for Psoriasis

    People suffering from psoriasis reported quick and extensive improvement of the psoriasis skin condition with new drug. The study published in The Lancet journal. 40% of people reported a complete clearance of psoriatic plaques after 12 weeks of treatment with the new drug and over 90% showed improvement.

  • Prognosis for breast cancer is relatively good when detected in its early stages, metastatic disease is the cause of 90 percent of all cancer-related deaths. Breast cancer patients with high levels of the protein activin-like receptor kinase (ALK1) in the blood vessels of their tumors were more likely to develop metastatic disease, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

  • Glenmark Pharmaceuticals, USA has been granted final approval by the United States Food & Drug Administration (FDA) for the extended-cycle oral contraceptive, levonorgestrel/ethinyl estradiol tablets USP, 0.15 mg/0.03 mg, the AB-rated generic version of Seasonale by Teva Women’s Health.

    [adsense:336x280:8701650588]

Subscribe to Pharma News